Edwards Lifesciences · Cash & Short-Term Investments

Latest reported$4.23Bperiod endingDec 31, 2025

EW FY Cash & Short-Term Investments ($0.00 → $4.23B)

Annual Cash & Short-Term Investments

High-resolution chart · PNG

EW cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Cash & Short-Term Investments — Annual fiscal periods (USD)
Period ending	Cash & Short-Term Investments (USD)
Dec 31, 2025	4,226,800,000
Dec 31, 2024	3,975,900,000
Dec 31, 2023	1,632,800,000
Dec 31, 2022	1,215,300,000
Dec 31, 2021	1,466,800,000
Dec 31, 2020	1,402,600,000
Dec 31, 2019	1,516,900,000
Dec 31, 2018	956,500,000
Dec 31, 2017	1,337,500,000
Dec 31, 2016	1,271,100,000
Dec 31, 2015	1,224,700,000
Dec 31, 2014	1,438,800,000
Dec 31, 2013	936,900,000
Dec 31, 2012	521,400,000
Dec 31, 2011	450,500,000
Dec 31, 2010	396,100,000
Dec 31, 2009	334,100,000
Dec 31, 2008	226,800,000
Dec 31, 2007	191,200,000
Dec 31, 2006	182,800,000
Dec 31, 2005	178,600,000
Dec 31, 2004	48,900,000
Dec 31, 2003	61,100,000
Dec 31, 2002	34,200,000
Dec 31, 2001	48,000,000
Dec 31, 2000	28,000,000
Dec 31, 1999	0